Identification of autoantibodies as potential non-invasive biomarkers for intrahepatic cholangiocarcinoma
Open Access
- 28 August 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-14
Abstract
Intrahepatic cholangiocarcinoma (iCCA) presents a challenging diagnosis due to its nonspecific early clinical manifestations, often resulting in late-stage detection and high mortality. Diagnosing iCCA is further complicated by its limited accuracy, often necessitating multiple invasive procedures for precise identification. Despite carbohydrate antigen 19–9 (CA19-9) having been investigated and employed for iCCA diagnosis, it demonstrates modest diagnostic performance. Consequently, the identification of novel biomarkers with improved sensitivity and specificity remains an imperative yet formidable task. Autoantibodies, as early indicators of the immune response against cancer, offer a promising avenue for enhancing diagnostic accuracy. Our study aimed to identify non-invasive blood-based autoantibody biomarkers capable of distinguishing iCCA patients from healthy individuals (CTRs). We profiled autoantibodies in 26 serum samples (16 iCCAs and 10 CTRs) using protein microarrays containing 1622 functional proteins. Leveraging machine learning techniques, we identified a signature composed of three autoantibody biomarkers (NDE1, PYCR1, and VIM) in conjunction with CA19-9 for iCCA detection. This combined signature demonstrated superior diagnostic performance with an AUC of 96.9%, outperforming CA19-9 alone (AUC: 83.8%). These results suggest the potential of autoantibody biomarkers to develop a complementary non-invasive diagnostic utility for routine iCCA screening.Keywords
Funding Information
- Chulabhorn Graduate Scholarship (CGS2562/01)
- Ministry of Higher Education, Science, Research and Innovation, and Thailand Science Research and Innovation (TSRI), Chulabhorn Research Institute (2536699/42113, 48292/4691968)
- Intramural Program of the Center for Cancer Research, National Cancer Institute
- Center of Excellence on Environmental Health and Toxicology (EHT), OPS
This publication has 61 references indexed in Scilit:
- Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and CholangiocarcinomaCancer Cell, 2017
- Autoantibody Production in Cancer—The Humoral Immune Response toward Autologous Antigens in Cancer PatientsAutoimmunity Reviews, 2016
- Immunogenicity of necrotic cell deathCellular and Molecular Life Sciences, 2014
- Protein Function Microarrays: Design, Use and Bioinformatic Analysis in Cancer Biomarker Discovery and Quantitation2012
- Protein Function Microarrays for Customised Systems-Oriented Proteome Analysis2011
- Vimentin in cancer and its potential as a molecular target for cancer therapyCellular and Molecular Life Sciences, 2011
- Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell originHepatology, 2008
- Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesisCancer Letters, 2005
- Fabrication of Protein Function Microarrays for Systems-Oriented Proteomic Analysis2005
- Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven casesCancer, 1993